Skip to content

Optimising Photodynamic Therapy for the Treatment of Head and Neck Cancer

Optimising Photodynamic Therapy for the Treatment of Head and Neck Cancer - Optimising PDT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34093
Enrollment
50
Registered
2010-09-24
Start date
2011-02-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancers

Interventions

None listed

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients included in the PDT arm of the study : *a multi-centre cost-effectiveness evaluation of a novel treatment option in the Netherlands: photo dynamic therapy with temoporfin for the treatment of advanced incurable head and neck cancers, for whom prior conventional treatments have failed* (PTC09.1229/M09PDT).

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
Study parameters:Spectrosopic quantitative analysis of oxygen saturation and mTHPC concentration in tumor tissue, light dosimetry, serum MTHPC concentration.

Secondary

MeasureTime frame
none

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)